Scholars Central

Conference abstractPublished 18 Nov 2014

Cholecalciferol (vitamin D 3) improves cognitive dysfunction and reduces inflammation in a rat fatty liver model of metabolic syndrome

Authors: Oytun Erbas

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic syndrome is a physiological state characterized by an increase in abdominal obesity, insulin resistance, atherogenic dyslipidemia (a decrease in HDL with a concomitant increase in triglycerides), hypertension, and inflammation. Increased adiposity and the development of fatty liver in addition to insulin resistance or type 2 diabetes mellitus are some of the most serious health outcomes in metabolic syndrome. Much research has been dedicated to understand and explain the processes contributing to metabolic syndrome. In recent years, inflammation has been found to be a causative factor of metabolic syndrome. Specifically, it has been reported that there is increased inflammation in metabolic syndrome that facilitates the development of hepatosteatosis. Cognitive dysfunction generally refers to deficits in memory and executive function, and many diseasesmay result in cognitive dysfunction. Besides metabolic disorders, cognitive dysfunction is most often associated with advanced age such as Alzheimer�s disease. The pathogenesis of Alzheimer�s disease is not yet fully understood, but a complex mechanismhas been recently proposed that involves insulin resistance and an increase in inflammation. According to this theory, increased peripheral insulin resistance causes increases in serum insulin levels that trigger both peripheral and central nervous system inflammation, which induces neurotoxicity as reactive oxygen species are produced in the brain. Several other studies have examined the relationship between metabolic syndrome and cognitive dysfunction. Cholecalciferol or vitamin D3 is synthesized in the human body and is a hormone precursor. Cholecalciferol is transformed into 1, 25- dihydroxycholecalciferol which is themost biologically active form after hydroxylation in the liver and kidney. Previous studies have demonstrated that this molecule has antiinflammatory and neuroprotective characteristics. In our study, we observed that vitamin D supplementation reduced TNF- α levels in the brain and MDA levels in the plasma in rats with hepatosteatosis. Moreover, rats with fatty liver that were given vitamin D imparts cognitive benefits in rats. Interestingly, rats with fatty liver and vitamin D supplementation had no apparent differences in liver histopathology and total body weight when compared to rats with fatty liver that did not receive vitamin D. These findings suggest that vitamin D may improve systemic and brain inflammation and benefit cognition as a result.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Oytun Erbas”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels